A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.
published in: Molecular Therapy
date of publication: 2014-02-27
main subject: phase I clinical trial, Herpes simplex virus type 1
Cites articles 29
Date
Title
Article - wd:Q33587028